Biobanking and Gene Expression - Clinical Research Informer

Alnylam identifies gene to lower abdominal fat and decrease cardiovascular risk

Pharmaceutical Technology

AUGUST 11, 2022

Alnylam Pharmaceuticals and collaborators have identified rare mutations in the INHBE gene that is expressed in the liver, related to a lower waist-to-hip ratio for body mass index (BMI), which is often used as an indicator of abdominal fat and is correlated with the risk of type 2 diabetes (T2D) and coronary heart disease.

Gene

Gene Biobanking Gene Expression In-Vitro

Artificial intelligence could be new blueprint for precision drug discovery

The Pharma Data

JULY 12, 2021

The AI approach helps model a disease using a map of successive changes in gene expression at the onset and during the progression of the disease. The underlying algorithms ensure that the identified gene expression patterns are ‘invariant’ regardless of different disease cohorts.

Drugs

Drugs Gene Expression Big Data Gene

Clinical Research Informer

Alnylam identifies gene to lower abdominal fat and decrease cardiovascular risk

Artificial intelligence could be new blueprint for precision drug discovery

Webinars

Stay Connected